Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Susan Geyer
Institution:
Mayo Clinic
Observed institution:
Mayo Clinic
OpenAlex ID:
A5149980879
Dual Immunotherapy in Aggressive Lymphoma (DIAL) study, a randomized phase 2 trial of Varlilumab in combination with Nivolumab in patients with relapsed/refractory B-cell non-Hodgkin lymphoma
2026
·
Rafael Hennemann Sassi
, Susan Geyer
, et al.
·
Research Square
PDF
Show more works
View as search
Works count:
1
Citation count:
H-index:
I10-index:
Year
Topic
Type
